Skip to main content
Erschienen in: Supportive Care in Cancer 8/2013

01.08.2013 | Original Article

Transient swelling versus lymphoedema in the first year following surgery for breast cancer

verfasst von: Sharon L. Kilbreath, Mi-Joung Lee, Kathryn M. Refshauge, Jane M. Beith, Leigh C. Ward, J. M. Simpson, D. Black

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim was to better understand the incidence, time course and risk factors for swelling in the arm on the side of surgery over the first year following surgery for breast cancer.

Method

Women (n = 160) were assessed 1 month following surgery and then randomised to the exercise or control group. Reassessment occurred 3, 9 and 15 months following surgery. Potential risk factors for swelling included age, body mass index, side of surgery and surgical and medical treatments for their breast cancer, physical measures of shoulder range of motion and strength, inter-limb arm circumference difference and the group to which they were randomised. Swelling was determined using bioimpedance spectroscopy with reference to previously established cut-offs for lymphoedema.

Results

The number of women with swelling at 3, 9 and 15 months was 15, 15 and 13, respectively; however, at 15 months only 5/13 presented with swelling in either of the preceding assessments. The risk of swelling increased at 3, 9 and 15 months for each centimetre increase in the baseline inter-limb difference in sum of arm circumferences by 1.30, 1.17 and 1.14. In addition, risk of swelling at 3 months was 2.6 times greater for women in the control group; at 9 months, 7 times greater for women who had taxane-based chemotherapy; and at 15 months, the risk increased 1.16 times for each day the drain was in situ.

Conclusion

Swelling in the first year is likely to be transient, and factors including exercise and taxane chemotherapy affect the risk of developing swelling.
Literatur
1.
Zurück zum Zitat Rockson SG: Update on the biology and treatment of lymphedema. Curr Treat Options Cardiovasc Med 2012. Rockson SG: Update on the biology and treatment of lymphedema. Curr Treat Options Cardiovasc Med 2012.
2.
Zurück zum Zitat Stanton AW, Modi S, Mellor RH, Levick JR, Mortimer PS (2009) Recent advances in breast cancer-related lymphedema of the arm: lymphatic pump failure and predisposing factors. Lymphat Res Biol 7(1):29–45PubMedCrossRef Stanton AW, Modi S, Mellor RH, Levick JR, Mortimer PS (2009) Recent advances in breast cancer-related lymphedema of the arm: lymphatic pump failure and predisposing factors. Lymphat Res Biol 7(1):29–45PubMedCrossRef
3.
Zurück zum Zitat Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, Miller LT, Demichele A, Solin LJ (2009) Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol 27(3):390–397PubMedCrossRef Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, Miller LT, Demichele A, Solin LJ (2009) Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol 27(3):390–397PubMedCrossRef
4.
Zurück zum Zitat Hayes SC, Janda M, Cornish B, Battistutta D, Newman B (2008) Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 26(21):3536–3542PubMedCrossRef Hayes SC, Janda M, Cornish B, Battistutta D, Newman B (2008) Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 26(21):3536–3542PubMedCrossRef
5.
Zurück zum Zitat Lane KN, Dolan LB, Worsley D, McKenzie DC, Lane KN, Dolan LB, Worsley D, McKenzie DC (2007) Upper extremity lymphatic function at rest and during exercise in breast cancer survivors with and without lymphedema compared with healthy controls. J Appl Physiol 103(3):917–925PubMedCrossRef Lane KN, Dolan LB, Worsley D, McKenzie DC, Lane KN, Dolan LB, Worsley D, McKenzie DC (2007) Upper extremity lymphatic function at rest and during exercise in breast cancer survivors with and without lymphedema compared with healthy controls. J Appl Physiol 103(3):917–925PubMedCrossRef
6.
Zurück zum Zitat Zawieja D (2005) Lymphatic biology and the microcirculation: past, present and future. Microcirculation 12(1):141–150PubMedCrossRef Zawieja D (2005) Lymphatic biology and the microcirculation: past, present and future. Microcirculation 12(1):141–150PubMedCrossRef
7.
Zurück zum Zitat Coates G, O’Brodovich H, Goeree G (1993) Hindlimb and lung lymph flows during prolonged exercise. J Appl Physiol 75(2):633–638PubMed Coates G, O’Brodovich H, Goeree G (1993) Hindlimb and lung lymph flows during prolonged exercise. J Appl Physiol 75(2):633–638PubMed
8.
Zurück zum Zitat McGeown JG, McHale NG, Thornbury KD (1987) The role of external compression and movement in lymph propulsion in the sheep hind limb. J Physiol 387:83–93PubMed McGeown JG, McHale NG, Thornbury KD (1987) The role of external compression and movement in lymph propulsion in the sheep hind limb. J Physiol 387:83–93PubMed
9.
Zurück zum Zitat Hormes JM, Bryan C, Lytle LA, Gross CR, Ahmed RL, Troxel AB, Schmitz KH (2010) Impact of lymphedema and arm symptoms on quality of life in breast cancer survivors. Lymphology 43(1):1–13PubMed Hormes JM, Bryan C, Lytle LA, Gross CR, Ahmed RL, Troxel AB, Schmitz KH (2010) Impact of lymphedema and arm symptoms on quality of life in breast cancer survivors. Lymphology 43(1):1–13PubMed
10.
Zurück zum Zitat Helyer LK, Varnic M, Le LW, Leong W, McCready D: Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J 2009:1–7. Helyer LK, Varnic M, Le LW, Leong W, McCready D: Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J 2009:1–7.
11.
Zurück zum Zitat Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HA, Potashnik SL, Miller LT, Fox KR, DeMichele A, Solin LJ (2010) Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev 19(11):2734–2746PubMedCrossRef Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HA, Potashnik SL, Miller LT, Fox KR, DeMichele A, Solin LJ (2010) Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev 19(11):2734–2746PubMedCrossRef
12.
Zurück zum Zitat Swenson KK, Nissen MJ, Leach JW, Post-White J (2009) Case–control study to evaluate predictors of lymphedema after breast cancer surgery. Oncol Nurs Forum 36(2):185–193PubMedCrossRef Swenson KK, Nissen MJ, Leach JW, Post-White J (2009) Case–control study to evaluate predictors of lymphedema after breast cancer surgery. Oncol Nurs Forum 36(2):185–193PubMedCrossRef
13.
Zurück zum Zitat Yen TW, Fan X, Sparapani R, Laud PW, Walker AP, Nattinger AB (2009) A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. Ann Surg Oncol 16(4):979–988PubMedCrossRef Yen TW, Fan X, Sparapani R, Laud PW, Walker AP, Nattinger AB (2009) A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. Ann Surg Oncol 16(4):979–988PubMedCrossRef
14.
Zurück zum Zitat Bronstad A, Berg A, Reed RK (2004) Effects of the taxanes paclitaxel and docetaxel on edema formation and interstitial fluid pressure. Am J Physiol Heart Circ Physiol 287(2):H963–968PubMedCrossRef Bronstad A, Berg A, Reed RK (2004) Effects of the taxanes paclitaxel and docetaxel on edema formation and interstitial fluid pressure. Am J Physiol Heart Circ Physiol 287(2):H963–968PubMedCrossRef
15.
Zurück zum Zitat Qin YY, Li H, Guo XJ, Ye XF, Wei X, Zhou YH, Zhang XJ, Wang C, Qian W, Lu J et al (2011) Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients. PLoS One 6(11):e26946PubMedCrossRef Qin YY, Li H, Guo XJ, Ye XF, Wei X, Zhou YH, Zhang XJ, Wang C, Qian W, Lu J et al (2011) Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients. PLoS One 6(11):e26946PubMedCrossRef
16.
Zurück zum Zitat Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P (2008) Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112(12):2809–2819PubMedCrossRef Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P (2008) Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112(12):2809–2819PubMedCrossRef
17.
Zurück zum Zitat Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Lee M, Simpson JM, Hansen R: Upper limb progressive resistance training and stretching exercises following surgery for early breast cancer: a randomized controlled trial. Breast Cancer Res Treat 2012. Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Lee M, Simpson JM, Hansen R: Upper limb progressive resistance training and stretching exercises following surgery for early breast cancer: a randomized controlled trial. Breast Cancer Res Treat 2012.
18.
Zurück zum Zitat Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Simpson JM, Hansen RD (2006) Progressive resistance training and stretching following surgery for breast cancer: study protocol for a randomised controlled trial. BMC Cancer 6:273PubMedCrossRef Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Simpson JM, Hansen RD (2006) Progressive resistance training and stretching following surgery for breast cancer: study protocol for a randomised controlled trial. BMC Cancer 6:273PubMedCrossRef
19.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef
20.
Zurück zum Zitat Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995) Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 13(5):1249–1254PubMed Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995) Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 13(5):1249–1254PubMed
21.
Zurück zum Zitat Cornish BH, Jacobs A, Thomas BJ, Ward LC (1999) Optimizing electrode sites for segmental bioimpedance measurements. Physiol Meas 20(3):241–250PubMedCrossRef Cornish BH, Jacobs A, Thomas BJ, Ward LC (1999) Optimizing electrode sites for segmental bioimpedance measurements. Physiol Meas 20(3):241–250PubMedCrossRef
22.
Zurück zum Zitat Ward LC, Kilbreath S, Cornish BH: Bioimpedance analysis for early detection of lymphedema. In: Lymphedema: Diagnosis and therapy. Edited by Weissieder H, Schuchhardt C, 4th edn. Essen: Viavital 2008: 502–517. Ward LC, Kilbreath S, Cornish BH: Bioimpedance analysis for early detection of lymphedema. In: Lymphedema: Diagnosis and therapy. Edited by Weissieder H, Schuchhardt C, 4th edn. Essen: Viavital 2008: 502–517.
23.
Zurück zum Zitat Karges JR, Mark BE, Stikeleather SJ, Worrell TW (2003) Concurrent validity of upper-extremity volume estimates: comparison of calculated volume derived from girth measurements and water displacement volume. Phys Ther 83(2):134–145PubMed Karges JR, Mark BE, Stikeleather SJ, Worrell TW (2003) Concurrent validity of upper-extremity volume estimates: comparison of calculated volume derived from girth measurements and water displacement volume. Phys Ther 83(2):134–145PubMed
24.
Zurück zum Zitat Ward LC, Dylke E, Czerniec S, Isenring E, Kilbreath SL (2011) Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy. Lymphat Res Biol 9(1):47–51PubMedCrossRef Ward LC, Dylke E, Czerniec S, Isenring E, Kilbreath SL (2011) Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy. Lymphat Res Biol 9(1):47–51PubMedCrossRef
25.
Zurück zum Zitat McNutt L-A, Wu C, Xue X, Hafner J (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157(10):940–943PubMedCrossRef McNutt L-A, Wu C, Xue X, Hafner J (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157(10):940–943PubMedCrossRef
26.
Zurück zum Zitat Armer JM, Stewart BR (2010) Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology 43(3):118–127PubMed Armer JM, Stewart BR (2010) Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology 43(3):118–127PubMed
27.
Zurück zum Zitat Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JK, Lane K et al (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25(28):4396–4404PubMedCrossRef Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JK, Lane K et al (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25(28):4396–4404PubMedCrossRef
28.
Zurück zum Zitat Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, Bryan CJ, Williams-Smith CT, Chittams J (2010) Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA 304(24):2699–2705PubMedCrossRef Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, Bryan CJ, Williams-Smith CT, Chittams J (2010) Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA 304(24):2699–2705PubMedCrossRef
29.
Zurück zum Zitat Cavanaugh KM (2011) Effects of early exercise on the development of lymphedema in patients with breast cancer treated with axillary lymph node dissection. J Oncol Pract 7(2):89–93PubMedCrossRef Cavanaugh KM (2011) Effects of early exercise on the development of lymphedema in patients with breast cancer treated with axillary lymph node dissection. J Oncol Pract 7(2):89–93PubMedCrossRef
30.
Zurück zum Zitat Cheema B, Gaul CA, Lane K, Singh MAF (2008) Progressive resistance training in breast cancer: a systematic review of clinical trials. Breast Cancer Res Treat 109(1):9–26PubMedCrossRef Cheema B, Gaul CA, Lane K, Singh MAF (2008) Progressive resistance training in breast cancer: a systematic review of clinical trials. Breast Cancer Res Treat 109(1):9–26PubMedCrossRef
31.
Zurück zum Zitat Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14(5):377–381PubMed Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14(5):377–381PubMed
32.
Zurück zum Zitat Matthews K, Smith J (1996) Effectiveness of modified complex physical therapy for lymphoedema treatment. Aust J Physiother 42(4):323–328PubMed Matthews K, Smith J (1996) Effectiveness of modified complex physical therapy for lymphoedema treatment. Aust J Physiother 42(4):323–328PubMed
33.
Zurück zum Zitat Ridner SH (2002) Breast cancer lymphedema: pathophysiology and risk reduction guidelines. Oncol Nurs Forum 29(9):1285–1293PubMedCrossRef Ridner SH (2002) Breast cancer lymphedema: pathophysiology and risk reduction guidelines. Oncol Nurs Forum 29(9):1285–1293PubMedCrossRef
34.
Zurück zum Zitat Lee TS, Kilbreath SL, Sullivan G, Refshauge KM, Beith JM, Harris LM (2009) Factors that affect intention to avoid strenuous arm activity after breast cancer surgery. Oncol Nurs Forum 36(4):454–462PubMedCrossRef Lee TS, Kilbreath SL, Sullivan G, Refshauge KM, Beith JM, Harris LM (2009) Factors that affect intention to avoid strenuous arm activity after breast cancer surgery. Oncol Nurs Forum 36(4):454–462PubMedCrossRef
35.
Zurück zum Zitat Schoeller D: Hydrometry. In: Human body composition. Edited by Roche A, Heymsfield S, Lohman T. Champaign, IL: Human Kinetics; 1996: 25–43. Schoeller D: Hydrometry. In: Human body composition. Edited by Roche A, Heymsfield S, Lohman T. Champaign, IL: Human Kinetics; 1996: 25–43.
36.
Zurück zum Zitat Stanton AW, Mellor RH, Cook GJ, Svensson WE, Peters AM, Levick JR, Mortimer PS (2003) Impairment of lymph drainage in subfascial compartment of forearm in breast cancer-related lymphedema. Lymphat Res Biol 1(2):121–132PubMedCrossRef Stanton AW, Mellor RH, Cook GJ, Svensson WE, Peters AM, Levick JR, Mortimer PS (2003) Impairment of lymph drainage in subfascial compartment of forearm in breast cancer-related lymphedema. Lymphat Res Biol 1(2):121–132PubMedCrossRef
37.
Zurück zum Zitat Stanton AW, Modi S, Bennett Britton TM, Purushotham AD, Peters AM, Levick JR, Mortimer PS (2009) Lymphatic drainage in the muscle and subcutis of the arm after breast cancer treatment. Breast Cancer Res Treat 117(3):549–557PubMedCrossRef Stanton AW, Modi S, Bennett Britton TM, Purushotham AD, Peters AM, Levick JR, Mortimer PS (2009) Lymphatic drainage in the muscle and subcutis of the arm after breast cancer treatment. Breast Cancer Res Treat 117(3):549–557PubMedCrossRef
38.
Zurück zum Zitat Cornish BH, Chapman M, Thomas BJ, Ward LC, Bunce IH, Hirst C (2000) Early diagnosis of lymphedema in postsurgery breast cancer patients. Ann N Y Acad Sci 904:571–575PubMedCrossRef Cornish BH, Chapman M, Thomas BJ, Ward LC, Bunce IH, Hirst C (2000) Early diagnosis of lymphedema in postsurgery breast cancer patients. Ann N Y Acad Sci 904:571–575PubMedCrossRef
39.
Zurück zum Zitat Czerniec SA, Ward LC, Refshauge KM, Beith J, Lee MJ, York S, Kilbreath SL (2010) Assessment of breast cancer-related arm lymphedema—comparison of physical measurement methods and self-report. Cancer Invest 28(1):54–62PubMedCrossRef Czerniec SA, Ward LC, Refshauge KM, Beith J, Lee MJ, York S, Kilbreath SL (2010) Assessment of breast cancer-related arm lymphedema—comparison of physical measurement methods and self-report. Cancer Invest 28(1):54–62PubMedCrossRef
40.
Zurück zum Zitat Lee TS, Kilbreath SL, Refshauge KM, Pendlebury SC, Beith JM, Lee MJ (2007) Pectoral stretching program for women undergoing radiotherapy for breast cancer. Breast Cancer Res Treat 102(3):313–321PubMedCrossRef Lee TS, Kilbreath SL, Refshauge KM, Pendlebury SC, Beith JM, Lee MJ (2007) Pectoral stretching program for women undergoing radiotherapy for breast cancer. Breast Cancer Res Treat 102(3):313–321PubMedCrossRef
41.
Zurück zum Zitat Alfano CM, Day JM, Katz ML, Herndon JE 2nd, Bittoni MA, Oliveri JM, Donohue K, Paskett ED (2009) Exercise and dietary change after diagnosis and cancer-related symptoms in long-term survivors of breast cancer: CALGB 79804. Psychooncology 18(2):128–133PubMedCrossRef Alfano CM, Day JM, Katz ML, Herndon JE 2nd, Bittoni MA, Oliveri JM, Donohue K, Paskett ED (2009) Exercise and dietary change after diagnosis and cancer-related symptoms in long-term survivors of breast cancer: CALGB 79804. Psychooncology 18(2):128–133PubMedCrossRef
Metadaten
Titel
Transient swelling versus lymphoedema in the first year following surgery for breast cancer
verfasst von
Sharon L. Kilbreath
Mi-Joung Lee
Kathryn M. Refshauge
Jane M. Beith
Leigh C. Ward
J. M. Simpson
D. Black
Publikationsdatum
01.08.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2013
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1770-2

Weitere Artikel der Ausgabe 8/2013

Supportive Care in Cancer 8/2013 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.